Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice
Paclitaxel is an effective antitumor agent used for treatment of breast cancer, lung, stomach and pancreas. However, its own adverse effects and the use of toxic Cremophor EL as the solvent limit the application range of this drug. Associated with the albumin-bound nanoparticle paclitaxel (paclitaxe...
Saved in:
Main Authors: | R. N. Alyautdin (Author), B. K. Romanov (Author), В. К. Лепахин (Author), N. D. Bunyatyan (Author), V. A. Merkulov (Author), A. N. Mironov (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Peripheral Neuropathy Induced by Standard and Nanoparticle Albumin-Bound Paclitaxel in Rats
by: Yuji Yamashita, et al.
Published: (2011) -
Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019) -
Baseline differences in metabolic profiles of patients with lung squamous cell carcinoma responding or not responding to treatment with nanoparticle albumin-bound paclitaxel (nab-paclitaxel)
by: Peng Cao, et al.
Published: (2023) -
Albumin-bound paclitaxel in solid tumors: clinical development and future directions
by: Kundranda MN, et al.
Published: (2015) -
Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
by: Zhichao Tian, et al.
Published: (2024)